Metropolitan Life Insurance Company (MetLife)’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,615
Closed -$22.9K 95
2024
Q1
$22.9K Sell
4,615
-813
-15% -$5.2K ﹤0.01% 1791
2023
Q4
$46.7K Hold
5,428
﹤0.01% 1485
2023
Q3
$37.7K Hold
5,428
﹤0.01% 1563
2023
Q2
$31.2K Hold
5,428
﹤0.01% 1697
2023
Q1
$34.5K Sell
5,428
-756
-12% -$7.21K ﹤0.01% 1596
2022
Q4
$72.7K Buy
6,184
+668
+12% +$8.13K ﹤0.01% 1243
2022
Q3
$65.3K Hold
5,516
﹤0.01% 1280
2022
Q2
$62.9K Hold
5,516
﹤0.01% 1344
2022
Q1
$61.9K Sell
5,516
-16,380
-75% -$147K ﹤0.01% 1469
2021
Q4
$308K Buy
21,896
+13,478
+160% +$236K ﹤0.01% 1729
2021
Q3
$135K Hold
8,418
﹤0.01% 2349
2021
Q2
$197K Buy
+8,418
New +$205K ﹤0.01% 2153

Other funds holding ALHC

Metropolitan Life Insurance Company (MetLife)'s ALHC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Alignment Healthcare (ALHC) in Q2 2024, closing a stake of 4,615 shares — an estimated $22.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALHC in Q2 2021 and held it in 12 quarters. The position peaked at $308K in Q4 2021. 118 funds tracked by Wall St. Rank hold ALHC as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Alignment Healthcare position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,615 Alignment Healthcare shares in Q2 2024, an estimated $22.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Alignment Healthcare in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Alignment Healthcare position peaked at $308K in Q4 2021.
  • 118 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.